6,278 results match your criteria: "Brugada Syndrome"

ECG in Brugada syndrome (BrS) is characterized by a ST-segment elevation in the right precordial leads. Overlap between ST-segment changes in BrS and ischemia may lead to diagnostic challenges. We report a case of a male patient presented with recurrent chest pain episodes and ST elevation in the right precordial leads consistent with Brugada ECG pattern type 1 and was clinically diagnosed with BrS at the age of 30 years.

View Article and Find Full Text PDF

Continuous electrocardiographic (ECG) monitoring remains crucial during surgery in infants and children. Although generally uncommon in pediatric-aged patients, ECG changes may occasionally be indicative of a variety of myocardial pathologies including anomalous origin of coronary arteries, ventricular hypertrophy, myocarditis, hypothermia, drug effects, electrolyte abnormalities, acid-base disturbances or conduction system disorders such as Wolff-Parkinson-White and Brugada syndrome. Distinguishing between pathologic and non-pathologic conditions impacting the ECG must be considered so that appropriate interventions are provided to prevent perioperative morbidity and mortality.

View Article and Find Full Text PDF

Brugada phenocopy in fulminant eosinophilic myocarditis: a case series.

Eur Heart J Case Rep

December 2024

Department of Cardiology, Tsuyama Chuo Hospital, 1756 Kawasaki, Tsuyama, Okayama 708-0841, Japan.

Background: Brugada phenocopy (BrP) is a condition that induces reversible Brugada-like electrocardiographic (ECG) changes in patients without true Brugada syndrome. We present two cases of fulminant eosinophilic myocarditis that showed Type 1 Brugada ECG changes in the early phase of the clinical course.

Case Summary: Case 1 was a 76-year-old man who developed fulminant eosinophilic myocarditis with ventricular tachycardia while hospitalized for heart failure.

View Article and Find Full Text PDF

[Clinical and electrocardiographic characteristics of carriers with SCN5A mutations and non-SCN5A mutations in fever-induced Brugada syndrome].

Zhonghua Xin Xue Guan Bing Za Zhi

December 2024

Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan430060, China.

To investigate the differences in clinical and electrocardiographic characteristics between carriers of SCN5A mutations and non-SCN5A mutations in fever-induced Brugada syndrome. This study is a retrospective cohort study. A total of 263 patients with fever-induced Brugada syndrome who were admitted to Renmin Hospital of Wuhan University from January 2000 to December 2023 were selected.

View Article and Find Full Text PDF

Non-invasive Assessment of HydroQUInidine EffecT in Brugada Syndrome (QUIET BrS).

Heart Rhythm

December 2024

Faculty of Medicine and Health, University of Sydney, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Australia. Electronic address:

Background: Hydroquinidine reduces arrhythmic events in patients with Brugada syndrome (BrS). The mechanism by which it exerts antiarrhythmic benefit and its electrophysiological effects on BrS substrate remain incompletely understood.

Objective: This study aimed to determine the effect of Hydroquinidine on ventricular depolarisation and repolarisation in patients with BrS in vivo.

View Article and Find Full Text PDF

A Matlab Toolbox for cardiac electrophysiology simulations on patient-specific geometries.

Comput Biol Med

December 2024

Research Center E. Piaggio, University of Pisa, L. Lazzarino, 1, Pisa, 56122, Italy; Information Engineering Department, University of Pisa, G. Caruso, 16, Pisa, 56122, Italy.

In this paper, we present CardioMat, a Matlab toolbox for cardiac electrophysiology simulation based on patient-specific anatomies. The strength of CardioMat is the easy and fast construction of electrophysiology cardiac digital twins from segmented anatomical images in a general-purpose software such as Matlab. CardioMat implements a quasi-automatic pipeline that guides the user toward the construction of anatomically detailed cardiac electrophysiology models.

View Article and Find Full Text PDF

Background: Diagnosis of Brugada syndrome (BrS) is based on type 1 morphology (coved type) in electrocardiograms from standard (4) or higher (2 or 3) intercostal spaces (ICSs). However, the clinical implications of being diagnosed only at higher ICSs remains poorly understood. We aimed to investigate the diagnostic accuracy of higher ICS leads in the Taiwanese Brugada syndrome population and clarify if there is any difference in clinical presentation.

View Article and Find Full Text PDF

Dynamic role of hormones on Brugada syndrome phenotype.

HeartRhythm Case Rep

November 2024

University of Wisconsin-Madison Inherited Arrhythmia Clinic, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin.

View Article and Find Full Text PDF

Genotype-phenotype association tests are typically adjusted for population stratification using principal components that are estimated genome-wide. This lacks resolution when analysing populations with fine structure and/or individuals with fine levels of admixture. This can affect power and precision, and is a particularly relevant consideration when control individuals are recruited using geographic selection criteria.

View Article and Find Full Text PDF

Background: Atrial tachyarrhythmias (ATAs) are the primary cause of inappropriate implantable cardioverter-defibrillator (ICD) therapy in patients with idiopathic ventricular fibrillation (IVF) and are associated with decreased quality of life and increased mortality. Nonetheless, the incidence of ATAs in IVF cases has not been clarified.

Objective: The study sought to determine the incidence and clinical significance of ATAs in patients with IVF compared with those with Brugada syndrome (BrS).

View Article and Find Full Text PDF

Objective: To identify the incidence and prevalence of type 1 Brugada pattern at Mayo Clinic during 30 years.

Methods: We retrospectively reviewed the electronic medical records from 1992 to 2021 at Mayo Clinic Enterprise. Patients with type 1 Brugada pattern electrocardiogram (ECG) were identified by a systematic keyword search.

View Article and Find Full Text PDF

In Vivo Mapping of Human Ventricular Fibrillation in Brugada Syndrome: The Role of Repolarization Heterogeneity.

Circ Arrhythm Electrophysiol

December 2024

Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart (L.P., D.G.D.R., P.V., A. Sorgente, A.D.M., G.V., M.C.F., G.T., I.E., P.-A.C., I.O., G.B., A.A., E.S., G.P., J.S., A.G., P.B., G.B.C., A. Sarkozy, C.d.A.), Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Belgium.

Article Synopsis
  • Brugada syndrome (BrS) is linked to dangerous heart rhythms called ventricular fibrillation (VF), and this study explores VF mapping using ECG imaging to understand the relationship between different VF mechanisms.* -
  • The researchers focused on patients diagnosed with BrS who experienced VF during a specific heart procedure, analyzing various heart rhythm maps to identify spatial correlations between repolarization gradients and VF triggers.* -
  • Results showed that most BrS patients had distinct "repolarization cliffs" that initiated VF, suggesting these cliffs could be important targets for treatment to prevent VF recurrence.*
View Article and Find Full Text PDF

The Role of Human-Induced Pluripotent Stem Cells in Studying Cardiac Channelopathies.

Int J Mol Sci

November 2024

Institute of Physiology, Department of Cellular and Translational Physiology, Ruhr-University Bochum, 44801 Bochum, Germany.

Article Synopsis
  • Cardiac channelopathies are inherited genetic disorders that increase the likelihood of sudden cardiac death, with some subtypes having unknown genetic causes.
  • Researchers are utilizing various models, particularly human-induced pluripotent stem-cell-derived cardiomyocytes (hiPSCs-CMs), to explore the mechanisms behind these disorders and their genotype-phenotype correlations.
  • Innovative techniques like CRISPR/Cas9 genome editing and 3D engineered heart tissues are being combined to enhance drug screening and develop personalized treatment options for conditions like Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia.
View Article and Find Full Text PDF

Drug-Induced Type 1 Brugada Pattern: A Case Report.

Cureus

November 2024

Internal Medicine, University Hospitals Sussex NHS Foundation Trust, St Richard's Hospital, Chichester, GBR.

Article Synopsis
  • Brugada syndrome is a genetic heart disorder characterized by abnormal heart rhythms, leading to fainting and potential sudden death, even in otherwise healthy individuals.
  • A 33-year-old man was diagnosed with drug-induced type 1 Brugada pattern after experiencing syncopal episodes that mimicked seizures, with no history of heart issues or epilepsy.
  • The antidepressant dosulepin was identified as the likely trigger for the condition, and a psychiatry consult was recommended to evaluate medication alternatives.
View Article and Find Full Text PDF

Acquired Type 1 Brugada Syndrome Induced by Chronic High-Dose Kratom Use.

Cureus

October 2024

Department of Emergency Medicine, Memorial Healthcare System, Hollywood, USA.

Article Synopsis
  • Kratom, a natural substance used for chronic pain and opioid withdrawal, has been linked to serious heart conditions, particularly Brugada syndrome.
  • A 36-year-old male with a history of substance abuse and underlying health conditions experienced chest pain, lightheadedness, and palpitations after using high doses of kratom for three years.
  • His case revealed a type 1 Brugada pattern on an EKG, leading to the diagnosis of Brugada syndrome as a result of chronic kratom use, emphasizing the need for medical professionals to be aware of the potential severe cardiac risks associated with kratom.
View Article and Find Full Text PDF
Article Synopsis
  • Brugada syndrome (BS) is a genetic condition that increases the risk of sudden cardiac death without any visible heart disease, making it important to assess which patients need an implantable cardioverter defibrillator (ICD).
  • The study involved comparing three groups: patients with type 1 BS (some had prior arrhythmic events, while others didn't) and age- and sex-matched healthy controls, focusing on EKG changes during exercise stress tests (EST).
  • Results showed that patients with prior arrhythmic events had a lower heart rate during exercise and a more significant decrease in heart rate during recovery compared to those without prior events, but no clear link was found between arrh
View Article and Find Full Text PDF
Article Synopsis
  • Brugada syndrome (BrS) is a hereditary heart condition that raises the risk of sudden cardiac death due to dangerous heart rhythms, and catheter ablation can help reduce these risks by targeting specific areas in the heart.
  • A 66-year-old male with BrS underwent a unique catheter ablation procedure using automated frequency mapping to locate and treat problematic heart regions, showing a significant reduction in dangerous heart abnormalities.
  • Follow-up results indicated successful outcomes with normalized ECG and no further occurrences of ventricular arrhythmias, highlighting the effectiveness of this automated mapping and ablation strategy.
View Article and Find Full Text PDF

A rare case of posterolateral ST-elevation myocardial infarction in Brugada syndrome: A double trouble beyond mimicking.

Kardiol Pol

November 2024

Department of Cardiology and Vascular Medicine, Faculty Medicine, Gorontalo State University, Jalan Jend. Sudirman No.6, Dulalowo Kecamatan Kota Tengah Kota, Gorontalo, Indonesia.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on using long-term implantable loop recorders (ILRs) to assess arrhythmia risk in patients with inherited arrhythmia syndromes who do not have a strong indication for implantable cardioverter defibrillator (ICD) implantation.
  • Researchers conducted a multicenter study from 2015 to 2020, enrolling 45 individuals, primarily with long-QT syndrome and Brugada syndrome, to monitor for arrhythmias and complications over time.
  • Results indicated that ILRs successfully identified significant arrhythmic events in 42% of patients, leading to ICD implantation in 11% of cases, and highlighted their potential to improve risk stratification without any occurrences of sudden cardiac death during the study
View Article and Find Full Text PDF